Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$25.04 - $30.06 $438,200 - $526,050
-17,500 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$27.43 - $32.7 $480,025 - $572,250
17,500 New
17,500 $433,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.92B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Privium Fund Management (Uk) LTD Portfolio

Follow Privium Fund Management (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management (Uk) LTD with notifications on news.